Sarcopenic obesity research perspectives outlined by the sarcopenic obesity global leadership initiative (SOGLI) – Proceedings from the SOGLI consortium meeting in rome November 2022

Gortan Cappellari G.;Guillet C.;Poggiogalle E.;Ballesteros Pomar M. D.;Batsis J. A.;Boirie Y.;Breton I.;Frara S.;Genton L.;Gepner Y.;Gonzalez M. C.;Heymsfield S. B.;Kiesswetter E.;Laviano A.;Prado C. M.;Santini F.;Serlie M. J.;Siervo M.;Villareal D. T.;Volkert D.;Voortman T.;Weijs P. J.;Zamboni M.;Bischoff S. C.;Busetto L.;Cederholm T.;Barazzoni R.;Donini L. M.;Bosy-Westphal A.;Brunani A.;Capodaglio P.;Coletti D.;Ferretti E.;Frigerio F.;Giustina A.;Lenzi A.;Marini E.;Migliaccio S.;Minnetti M.;Mocini E.;Moro T.;Muscaritoli M.;Noirez P.;Paoli A.;Rondanelli M.;Rughetti A.;Schoufour J. D.;Skalska A.;Topinkova E.;Wakabayashi H.;Yu J.

2023-01-01

---

Abstract

The European Society for Clinical Nutrition and Metabolism (ESPEN) and the European Association for the Study of Obesity (EASO) launched the Sarcopenic Obesity Global Leadership Initiative (SOGLI) to reach expert consensus on a definition and diagnostic criteria for Sarcopenic Obesity (SO). The present paper describes the proceeding of the Sarcopenic Obesity Global Leadership Initiative (SOGLI) meeting that was held on November 25th and 26th, 2022 in Rome, Italy. This consortium involved the participation of 50 researchers from different geographic regions and countries. The document outlines an agenda advocated by the SOGLI expert panel regarding the pathophysiology, screening, diagnosis, staging and treatment of SO that needs to be prioritized for future research in the field.